Correlation Between Hypertension and Hyponatremia in Hospitalized Coronavirus Disease 2019 Patients: A Single-Center Experience

Ayu Pramitha Wulandari, Dhani Tri Wahyu Nugroho

Abstract


Background: Hypertension has been presumed to be associated with the severity of coronavirus disease (COVID-19) related to angiotensin-converting enzyme 2 (ACE2). Besides, hyponatremia is the most common electrolyte disorder in COVID-19 patients and has been reported to be associated with increased mortality.

Objective: This study aimed to evaluate the association between hypertension and hyponatremia in COVID-19 patients who were admitted to Wahidin Sudirohusodo General Hospital Mojokerto.

Method: In this study, we cross-sectionally investigated COVID-19 patients who were admitted to Wahidin Sudirohusodo General Hospital Mojokerto between December 2020 and January 2021. According to medical records, we evaluated COVID-19 patients who have hypertension as comorbidities and hyponatremia from laboratory results.

Result: There were 98 COVID-19 patients enrolled in this study. The prevalence was 51 % men and 49 % women. The mean number of patients age was 55.6 + 12.4 years. The prevalence of hypertension among patients was 55.1%. The mean number of sodium level was 131.50 + 11.29 mmol/L. There was a strong correlation between blood pressure and sodium balance disorders (p<0,002). Hypertension was associated with a nearly 5.5-fold increased risk of hyponatremia in COVID-19 patients (OR 5.06; 95% CI; 1.66-15.4; p<0,05).

Conclusion: Hypertension comorbidity was associated with a higher risk of hyponatremia in COVID-19 patients.

Keywords: Hypertension, Hyponatremia, COVID-19


Keywords


Hypertension, Hyponatremia, COVID-19

Full Text:

PDF

References


Pan W., Zhang J., Wang M. et al. Clinical features of COVID-19 in patients with essential hypertension and the impacts of renin-angiotensin-aldosterone system inhibitors on the prognosis of COVID-19 patients. Hypertension 2020; (76): 1-10.

Shibata S, Arima H, Asayama K, et al.: Hypertension and related diseases in the era of COVID-19: a report from the Japanese Society of Hypertension Task Force on COVID-19. Hypertens Res 43(10):1028-1046, 2020.

Xiao L, Sakagami H, Miwa N: ACE2: The key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel? Viruses 12(5), 2020.

Lim JH., Jung HY., Choi JY., et al. Hypertension and electrolyte disorders in patients with COVID-19. Electrolyte Blood Press 2020; (18): 23-30.

Berni A, Malandrino D, Parenti G, et al.: Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together? J Endocrinol Invest 43(8):1137-1139, 2020.

Gupta A, Madhavan MV, Sehgal K, et al.: Extrapulmonary manifestations of COVID-19. Nat Med 26(7):1017-1032, 2020.

Xiao L, Sakagami H, Miwa N: ACE2: The key molecule for understanding the pathophysiology of severe and critical conditions of COVID-19: demon or angel? Viruses 12(5), 2020.

Gheblawi M, Wang K, Viveiros A, et al.: Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system. Circ Res 126(10):1456-1474, 2020.

D'Ardes D, Boccatonda A, Rossi I, et al.: COVID-19 and RAS: unravelling an unclear relationship. Int J Mol Sci 21(8):3003, 2020.

Santos RAS, Sampaio WO, Alzamora AC, et al.: The ACE2/ angiotensin-(1-7)/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7). Physiol Rev 98(1):505-553, 2018.

Santos RA, Ferreira AJ, Verano-Braga T, Bader M: Angiotensin- converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J Endocrinol 216(2):R1-R17, 2013.

Hong X-w, Chi Z-p, Liu G-y, et al.: Analysis of early renal injury in COVID-19 and diagnostic value of multi-index combined detection. medRxiv 2020. 03.07.20032599, 2020.

Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM: Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): early report from the United States. Diagnosis 7(2):91, 2020.

J. Alexandre, JL. Cracowski, V.Richard., et al. Renin-angiotensin-aldosterone system and COVID-19 infection. Annales d’endocrinologie 81 (2020): 63-67.




DOI: https://doi.org/10.21776/ub.hsj.2021.002.02.5

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Ayu Pramitha Wulandari, Dhani Tri Wahyu Nugroho

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.